EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Combined Effects of Anti-PD-L1 and Nanosonodynamic Therapy on HCC Immune Activation in Mice: An Investigation

Meng Wei, Xiaobo Wang, Yunhai Mo, Cunqing Kong iD, Mengqi Zhang iD, Guanhua Qiu, Zhihong Tang iD, Jie Chen, Feixiang Wu

International Journal of Nanomedicine · 2024

DOI: 10.2147/ijn.s427144 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2024. Verfasst von Meng Wei und 8 weiteren Autor:innen. Beteiligte Einrichtung: Hepatobiliary Surgery Department, Guangxi Medical University Cancer Hospital, Nanning, 530021, People's Republic of China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Nanoparticles, Liver Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularNanoparticlesLiver NeoplasmsAnimalsMiceCell Line, TumorB7-H1 AntigenHumansIndolesImmune Checkpoint InhibitorsUltrasonic TherapyOligopeptidesImmunogenic Cell DeathMicellesCombined Modality TherapyMice, Inbred BALB CImmunotherapy

Stichwörter der Autor:innen

PD-L1immunogenic cell deathnanomaterialssonodynamic therapytumor immunity

Substanzen

2-(2-(2-chloro-3-((1,3-dihydro-3,3-dimethyl-1-propyl-2H-indol-2-ylidene)ethylidene)-1-cyclohexen-1-yl)ethenyl)-3,3-dime…B7-H1 AntigenIndolesImmune Checkpoint InhibitorsOligopeptidesMicelles

Autor:innen und Institutionen

  • Hepatobiliary Surgery Department, Guangxi Medical University Cancer Hospital, Nanning, 530021, People's Republic of China.
  • Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor, Ministry of Education/Guangxi Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor, Nanning, 530021, Peop…
  • Medical Imaging Center, Affiliated Taihe Hospital, Hubei University of Medicine, Hubei, 442000, People's Republic of China.
  • Department of Interventional Therapy, Guangxi Medical University Cancer Hospital, Nanning, 530021, People's Republic of China.
  • Department of Ultrasound, Guangxi Medical University Cancer Hospital, Nanning, 530021, People's Republic of China.

ORCID-Profile: Cunqing Kong, Mengqi Zhang, Zhihong Tang

Zitieren

APA

Wei, M., Wang, X., Mo, Y., Kong, C., Zhang, M., Qiu, G., Tang, Z., Chen, J., & Wu, F. (2024). Combined Effects of Anti-PD-L1 and Nanosonodynamic Therapy on HCC Immune Activation in Mice: An Investigation. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s427144

Vancouver

Wei M, Wang X, Mo Y, Kong C, Zhang M, Qiu G, et al. Combined Effects of Anti-PD-L1 and Nanosonodynamic Therapy on HCC Immune Activation in Mice: An Investigation. International Journal of Nanomedicine. 2024. doi:10.2147/ijn.s427144

BibTeX
@article{Wei2024,
  author = {Wei, Meng and Wang, Xiaobo and Mo, Yunhai and Kong, Cunqing and Zhang, Mengqi and Qiu, Guanhua and Tang, Zhihong and Chen, Jie and Wu, Feixiang},
  title = {Combined Effects of Anti-PD-L1 and Nanosonodynamic Therapy on HCC Immune Activation in Mice: An Investigation},
  journal = {International Journal of Nanomedicine},
  year = {2024},
  doi = {10.2147/ijn.s427144}
}
Kostenlos starten →